Investigational new drug: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
An investigational new drug (IND) is a drug, antibiotic drug, or biological drug that is used in a clinical investigation. It also includes a biological product used in vitro for diagnostic purposes. | An investigational new drug (IND) is a drug, antibiotic drug, or biological drug that is used in a clinical investigation. It also includes a biological product used in vitro for diagnostic purposes. | ||
An IND filing with the FDA is required before starting [[clinical testing]]. | An IND filing with the [[FDA]] is required before starting [[clinical testing]]. | ||
Revision as of 13:55, 13 September 2007
An investigational new drug (IND) is a drug, antibiotic drug, or biological drug that is used in a clinical investigation. It also includes a biological product used in vitro for diagnostic purposes.
An IND filing with the FDA is required before starting clinical testing.